Inpatients with a mild presentation of IPEX, a mutation in FOXP3  was recently identified that did not interfere with protein expression but that did result in a partial defect in CD4+CD25+ regulatory T cell immunosuppression [10]. This evidence concerns the gene FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.